Screener Summaries Updates Institutions Sign In More Updates › Leadership & Pay › STAA Leadership & Pay · Jun 9, 2026
On June 8, 2026, STAAR Surgical Company's Compensation Committee approved an increase to the annual base salary of… STAA Staar Surgical Co
On June 8, 2026, STAAR Surgical Company's Compensation Committee approved an increase to the annual base salary of Interim Co-CEO and CFO Deborah Andrews to $575,000, up from $512,000. The Committee also increased her target annual cash bonus from 55% to 60% of her base salary, effective immediately. STAAR Surgical Company is a medical device company that manufactures and sells intraocular lenses.
More from Staar Surgical Co STAAR Surgical reports Q3 net income of $5.6M and authorizes $50M share buyback program Nov 4, 2026 STAAR Surgical appoints former CEO David Bailey as Chief Commercial Officer Oct 5, 2026 STAAR Surgical Company appointed David Bailey as Chief Commercial Officer, effective September 8, 2026 Sep 9, 2026 STAAR Surgical Company reported second quarter 2026 financial results for the period ended July 3, 2026 Aug 12, 2026 STAAR Surgical Company appointed Warren Foust as President and Chief Executive Officer, effective August 4, 2026… Aug 6, 2026 All content on this site is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Past performance is not indicative of future results. Always consult a qualified financial advisor before making investment decisions.
Financial data is obtained from public filings and third-party providers and is provided “as-is” without any guarantee of accuracy, completeness, or timeliness.
© 2026 go-intrinsic.com. All rights reserved.
